Drug-labels.com

Sumatriptan Df: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
25 mg, 50 mg, 100 mg

Patient Medication Information: uses, side effects, how to take - Sumatriptan Df

What is SUMATRIPTAN DF used for?

SUMATRIPTAN DF is used in adults to relieve migraine headaches. These migraine headaches may or may not be accompanied by an aura. This is when you may see black spots, flashes of light or shimmering spots or stars. SUMATRIPTAN DF should not be used to prevent or reduce the number of headaches you experience. Use SUMATRIPTAN DF only to treat an actual migraine headache attack.

How does SUMATRIPTAN DF work?

Migraine headache is believed to be caused by a widening of the blood vessels in the head. SUMATRIPTAN DF narrows these vessels and relieves the symptoms of migraine headache.

What are the ingredient in SUMATRIPTAN DF?

Medicinal ingredients: Sumatriptan succinate.

Nonmedicinal ingredients:

SUMATRIPTAN DF (25 mg, 50 mg and 100 mg Tablets): colloidal silicon dioxide, crospovidone, lactose, magnesium stearate and microcrystalline cellulose.

The film-coating for the 25 mg and 50 mg tablets for SUMATRIPTAN DF consists of hydroxypropyl methylcellulose, polydextrose, polyethylene glycol, titanium dioxide and triacetin.

The film-coating for the 100 mg tablet for SUMATRIPTAN DF consists of hydroxypropyl methylcellulose, polydextrose, polyethylene glycol, synthetic red iron oxide, titanium dioxide and triacetin.

SUMATRIPTAN DF comes in the following dosage forms:

SUMATRIPTAN DF tablets are available as 100 mg (pink), 50 mg (white to off white), 25 mg (white to off white).

Do not use SUMATRIPTAN DF if:

  • you are allergic to sumatriptan or to any of the ingredients in SUMATRIPTAN DF (See “What are the ingredients in SUMATRIPTAN DF?”).
  • you have a heart problem such as heart failure or chest pains (angina), or have already had a heart attack.
  • you have had a stroke or a mini-stroke (also called a transient ischaemic attack or TIA).
  • you have a history, symptoms or signs of peripheral vascular disease. This is a reduced blood flow to the limbs and organs other than the heart and brain, such as ischemic bowel disease and Raynaud’s syndrome. you have uncontrolled or severe high blood pressure.
  • you are taking or have taken within the past 2 weeks, a monoamine oxidase inhibitor (MAO) inhibitor, medication (such as phenelzine sulfate, tranylcypromine sulfate, moclobemide or selegiline).
  • you are taking or have taken within the past 24 hours, medication containing ergotamine, dihydroergotamine, methysergide, or another triptan used to treat migraine headaches. If you are not sure if you have been prescribed these types of medications, ask your healthcare professional.
  • you have severe liver problems.
  • you have certain other types of migraine headaches including:

    • hemiplegic migraines. These are migraine headaches where you have weakness on one side of your body, or
    • basilar migraines. These are migraine headaches that start in the lower part of the brain, or
    • ophthalmoplegic migraines. These are migraine headaches where you have pain around the eyes.

If you are not sure if you have these types of migraines, ask your healthcare professional.

SUMATRIPTAN DF Tablets should not be used for the treatment of other types of headaches that are different from migraine attacks.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take SUMATRIPTAN DF. Talk about any health conditions or problems you may have, including if you:

  • are pregnant, think you might be pregnant or you are trying to become pregnant.

  • are breastfeeding. The active ingredient in SUMATRIPTAN DF, will pass into

    your breast milk. Avoid breastfeeding for 24 hours after taking SUMATRIPTAN DF.

  • have risk factors for heart disease. This includes high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or you are postmenopausal or a male over 40.
  • have ever had to stop taking this or any other medication because of an allergy or other problems, or you are allergic to drugs containing sulphonamides.
  • are under 18 years of age.
  • are over 65 years of age.
  • had or have any liver or kidney problems.
  • had or have epilepsy or seizures.
  • experience a headache that is different from your usual migraine attacks.

Other warnings you should know about:

Taking SUMATRIPTAN DF can cause serious side effects, including:

  • Serious heart problems
  • Long term eye problems
  • Raynaud’s Syndrome

See the Serious side effects and what to do about them table, below for more information on these and other serious side effects.

Serotonin toxicity (also know as Serotonin syndrome): SUMATRIPTAN DF can cause serotonin toxicity, a rare but potentially life-threatening condition. It can cause serious changes in how your brain, muscles and digestive system work. You may develop serotonin toxicity if you take SUMATRIPTAN DF with certain medication to treat depression.

Serotonin toxicity symptoms include:

  • fever, sweating, shivering, diarrhea, nausea, vomiting;
  • muscle shakes, jerks, twitches or stiffness, overactive reflexes, loss of coordination;
  • fast heartbeat, changes in blood pressure;
  • confusion, agitation, restlessness, hallucinations, mood changes, unconsciousness, and coma.

Continuous use of SUMATRIPTAN DF: SUMATRIPTAN DF should not be used continuously to prevent or reduce the number of attacks you experience. Use SUMATRIPTAN DF only to treat an actual migraine headache attack. If you use SUMATRIPTAN DF too often, it may make your migraine headaches worse. If this happens, your healthcare professional may tell you to stop taking SUMATRIPTAN DF.

Driving and Operating Machines: SUMATRIPTAN DF can cause dizziness which may affect your ability to drive or use machines. Wait to see how you respond to SUMATRIPTAN DF before you drive or use machines.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with SUMATRIPTAN DF:

  • Medicines used to treat depression such as MAO Inhibitors, selective serotonin reuptake inhibitors (SSRIs), and serotonin noradrenaline reuptake inhibitors (SNRIs).
  • Other medicines used to treat migraine headaches such as triptans, 5-HT1 agonists, ergotamine, dihydroergotamine, and methysergide.

How to take SUMATRIPTAN DF:

  • Take SUMATRIPTAN DF with water and swallow the tablet whole. SUMATRIPTAN DF should not be chewed, divided or crushed.
  • SUMATRIPTAN DF can be taken at any time during your migraine headache.
  • It may take up to 30 minutes for SUMATRIPTAN DF to start working.
  • If after taking SUMATRIPTAN DF you need more pain relief, you can take another pain medication. This medication should not contain ergotamine. If you are not sure which medications you can use talk to your healthcare professional.
  • For subsequent migraine headaches, you may take SUMATRIPTAN DF.

Remember, this medicine has been prescribed only for you. Do not give it to anybody else, as they may experience undesirable effects, which may be serious.

Usual dose:

  • The usual adult dose is 50 mg.
  • Based on your response and tolerability, your healthcare professional may increase your dose to 100 mg. The maximum dose is 100 mg.
  • If you do not respond to the first dose of SUMATRIPTAN DF, do not take a second dose for the same attack
  • If your symptoms come back, and it has been two or more hours since your first tablet, you may take a second tablet.
  • Do not take more than 200 mg in any 24 hour period.

Overdose:

If you think you, or a person you are caring for, have taken too much SUMATRIPTAN DF, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

What are possible side effects from using SUMATRIPTAN DF?

These are not all the possible side effects you may feel when taking SUMATRIPTAN DF. If you experience any side effects not listed here, contact your healthcare professional.

The most commonly reported side effects of SUMATRIPTAN DF are:

  • flushing (redness of the face lasting for a short time)
  • feeling sick or vomiting
  • dizziness
  • drowsiness
  • tiredness
  • weakness
  • temporary increase in blood pressure
  • aching muscles

Other side effects include:

  • trouble with eyesight, such as blind spots, flashes of light, and seeing two images of a single object
  • shaking, tremors or uncontrolled movements
  • loss of normal colour in the fingers and toes
  • diarrhea
  • sweating

Serious side effects and what to do about them

Symptom/effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Common
Unusual sensations or discomfort including numbness, tingling, feeling hot or cold; pain, heaviness or pressure in any part of the body including chest, throat, neck, jaw and upper limbs.√
Very rare
Symptoms of a heart attack: chest pain, sweating, shortness of breath.√
Heart rhythm problems: unusually slow or fast heartbeats, or a feeling of irregular and/or forceful heartbeats.√
Allergic reactions:√
shortness of breath, sudden wheeziness, chest tightness, swelling of the eyelids, face or lips, lumpy skin rash or hives.
Seizures: loss of consciousness with uncontrollable shaking (“fit”).√
Lower abdominal pain and/or severe rectal bleeding.√
Raynaud’s syndrome: persistent purple discolouration of hands or feet.√
Loss of vision√
UNKNOWN
Serotonin toxicity: a reaction which may cause feelings of agitation or restlessness, flushing, muscle twitching, involuntary eye movements, heavy sweating, high body temperature (>38 °C), or rigid muscles.√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Keep your tablets in a cool, dry place (15°C to 30°C).

Medicines should not be disposed of via wastewater or household waste. Your healthcare professional will throw away any medicines that are no longer being used. These measures will help protect the environment.

Keep out of reach and sight of children.

If you want more information about SUMATRIPTAN DF:

  • Talk to your healthcare professional
  • Find the full Product Monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website http://www.sivem.ca; or by calling 1-855-788-3153.

Last revised: May 9, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02385562

Revision date stated in the text: May 9, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Sumatriptan Df

Rx or OTC
Prescription (Rx)?
DIN 02385562, 02385570, 02385589
Schedule(s) PRESCRIPTION
Active ingredient(s) Sumatriptan (sumatriptan succinate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02C Antimigraine preparations
        1. N02CC Selective serotonin (5HT1) agonists, antimigraine drugs
          1. N02CC01 Sumatriptan
Company SIVEM PHARMACEUTICALS ULC
Strengths and forms
DIN Strength Dosage form(s) Current status
02385562 25 MG Tablet Approved June 1, 2023
02385570 50 MG Tablet Marketed June 1, 2023
02385589 100 MG Tablet Marketed June 1, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.